Document is current
Any future updates will be listed below
-
Authors
Deng, Yong
Mo, Juan
Chun, Liu
Wang, Ning
Cao, Jing
Montufar Mejia, Amy Micaela
Montufar Mejia, Domenica Camila
Malik, Muhammad Adil
Henrio Marcellin, Dama Faniriantsoa https://orcid.org/0000-0002-5169-7077
Li, Xiaowu
Chen, Zhong
-
Funding
Funding for this research was provided by:
Combined Detection of TIM4 and Vitamin D in Patients with HBV-ACLF (202203083727)
- License Information
-
More Information
Article History
Received: 16 December 2025
Accepted: 22 January 2026
First Online: 4 February 2026
Declarations
:
: The study protocol (including amendments for extended recruitment through 2025 and TIM4 analysis) was reviewed and approved by the Medical Ethics Committee of The First Hospital of Changsha City [Approval No.: (2021) Ethical Review (Clinical Research) No.6]. This approval covered the entire study period (January 2024-October 2025) through approved amendments. All procedures were conducted in accordance with the Declaration of Helsinki and its later amendments. All participants provided written informed consent before participation. They were informed of the study’s purpose, their right to refuse or withdraw at any time, and the confidentiality of their responses. No minors were involved in the study.
: Not applicable.
: The authors declare no competing interests.
